Literature DB >> 21538710

Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge.

Sharmeel K Wasan1, Jennifer A Coukos, Francis A Farraye.   

Abstract

BACKGROUND: Current therapy for inflammatory bowel disease (IBD) patients often involves agents that suppress the immune system, placing patients at an increased risk for developing infections, of which several are potentially vaccine preventable. Many IBD patients are not being vaccinated appropriately. The aims of this study were to assess gastroenterologist's knowledge regarding vaccinating the IBD patient, eliciting the barriers that prevent vaccinations, and defining the gastroenterologist's role in vaccinations.
METHODS: One thousand gastroenterologists, randomly selected from the membership of the American College of Gastroenterology, were asked to complete a 19 question electronic survey regarding the suitable vaccines for the immunocompetent and immunosuppressed IBD patient and the barriers to recommending the vaccines. The perceived role of the gastroenterologist versus the primary care physician (PCP) was also assessed.
RESULTS: In all, 108 responses were analyzed; 68 (62%) gastroenterologists managed 40+ IBD patients, with 65 (52%) asking their patients about immunization history most or all of the time. The majority believed that the PCP should determine which vaccinations to give (64%) and to administer the vaccines (83%). Overall, 66%-88% of gastroenterologists correctly recommended the inactivated vaccines for their IBD patients not on immunosuppressive therapies while 20%-30% incorrectly recommended administering the live vaccines to their immunosuppressed patients.
CONCLUSIONS: Gastroenterologist knowledge of the appropriate immunizations to recommend to the IBD patient is poor and may be the primary reason why the majority of gastroenterologists believe that the PCP should be responsible for vaccinations. Educational programs on vaccinations directed to gastroenterologists who prescribe immunosuppressive agents are needed.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538710     DOI: 10.1002/ibd.21667

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  47 in total

Review 1.  Clinical pearls in gastroenterology 2011.

Authors:  Amy S Oxentenko; John B Bundrick; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

2.  Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System.

Authors:  Nalini Valluru; Le Kang; Jill K J Gaidos
Journal:  Dig Dis Sci       Date:  2018-05-08       Impact factor: 3.199

Review 3.  A Practical Guide to the Safety and Monitoring of New IBD Therapies.

Authors:  Benjamin Click; Miguel Regueiro
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

4.  Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFα Therapy.

Authors:  Katrine R Christensen; Casper Steenholdt; Sine S Buhl; Mark A Ainsworth; Ole Ø Thomsen; Jørn Brynskov
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

Review 5.  ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Authors:  Francis A Farraye; Gil Y Melmed; Gary R Lichtenstein; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

6.  Crohn's disease: the subsequent visit.

Authors:  Catherine S Manolakis; Francis A Farraye; Jack A Di Palma
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

7.  Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United States.

Authors:  Florian Rieder; Benjamin L Cohen; Jennifer L Dotson; Meenakshi Bewtra; Ashwin N Ananthakrishnan; Tolulope O Falaiye; Christina Y Ha
Journal:  Inflamm Bowel Dis       Date:  2016-06       Impact factor: 5.325

8.  Split dose and MiraLAX-based purgatives to enhance bowel preparation quality becoming common recommendations in the US.

Authors:  Grace Clarke Hillyer; Benjamin Lebwohl; Corey H Basch; Charles E Basch; Fay Kastrinos; Beverly J Insel; Alfred I Neugut
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 9.  Efficacy of the vaccination in inflammatory bowel disease.

Authors:  Elisa Carrera; Rebeca Manzano; Elena Garrido
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

10.  Shortened surveillance intervals following suboptimal bowel preparation for colonoscopy: results of a national survey.

Authors:  Grace Clarke Hillyer; Corey H Basch; Benjamin Lebwohl; Charles E Basch; Fay Kastrinos; Beverly J Insel; Alfred I Neugut
Journal:  Int J Colorectal Dis       Date:  2012-08-12       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.